RADIANT STUDY IS THE FIRST CONTROLLED PHASE II TRIAL TO INVESTIGATE THE EFFICACY OF HUMAN NEURAL STEM CELLS FOR THE TREATMENT OF DRY AMD

Radiant(TM) Study is the First Controlled Phase II Trial to Investigate the Efficacy of Human Neural Stem Cells for the Treatment of Dry AMD NEWARK, Calif., July 20, 2015 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM), a world leader in the research and development of cell-based therapeutics for the treatment of disorders of the brain, eye […]

Anuncio publicitario

Leer Más "RADIANT STUDY IS THE FIRST CONTROLLED PHASE II TRIAL TO INVESTIGATE THE EFFICACY OF HUMAN NEURAL STEM CELLS FOR THE TREATMENT OF DRY AMD"